<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03717870</url>
  </required_header>
  <id_info>
    <org_study_id>SAFE-1</org_study_id>
    <nct_id>NCT03717870</nct_id>
  </id_info>
  <brief_title>Surgery and ART For Endometrioma</brief_title>
  <official_title>Evaluation of Reproductive Outcomes After Different Management of Ovarian Endometrioma Prior to Assisted Reproduction Technology (ART): Laparoscopic Enucleation Vs Prolonged Pituitary Downregulation With Gonadotropin Releasing Hormone (GnRH)-Agonists</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università degli Studi dell'Insubria</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università degli Studi dell'Insubria</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endometriosis is an estrogen-dependent chronic disease, characterized by the presence of&#xD;
      endometrial-like tissue, glands and stroma outside the uterine cavity. Although endometriosis&#xD;
      is classified in four stage (minimal, mild, moderate, severe), from the clinical point of&#xD;
      view it is possible to subdivide among peritoneal superficial lesions, ovarian endometriomas&#xD;
      and Deep Infiltrating Endometriosis (DIE).&#xD;
&#xD;
      According to the European Society for Human Reproduction and Embryology (ESHRE) Guideline on&#xD;
      the management of women with endometriosis, it is recommended to clinicians that in infertile&#xD;
      women with endometrioma larger than 3 cm, cystectomy should be considered prior to Assisted&#xD;
      Reproduction Technology (ART) to improve endometriosis-associated pain or the accessibility&#xD;
      of follicles. They further recommend that clinicians counsel women with endometrioma&#xD;
      regarding the risks of reduced ovarian function after surgery, the possible loss of the&#xD;
      ovary, and consider that the decision to proceed with surgery should be taken carefully if&#xD;
      the woman has had previous ovarian surgery.&#xD;
&#xD;
      In addition, this Guideline suggests that clinicians can prescribe prolonged (3-6 months)&#xD;
      pituitary downregulation with Gonadotropin Releasing Hormone-agonists (GnRH-a) prior to ART,&#xD;
      in order to increase live birth rate by four-fold.&#xD;
&#xD;
      Despite these recommendations, to date there is not robust evidence to choose between the two&#xD;
      strategies prior to ART in order to improve reproductive outcomes.&#xD;
&#xD;
      For this reason, the aim of the current study will be to compare reproductive outcomes in&#xD;
      infertile women affected by ovarian endometrioma, undergoing laparoscopic enucleation or&#xD;
      prolonged pituitary downregulation with GnRH-a, prior to ART.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2023</start_date>
  <completion_date type="Anticipated">October 2027</completion_date>
  <primary_completion_date type="Anticipated">October 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized Controlled Trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical pregnancy with fetal heartbeat</measure>
    <time_frame>Within 8 weeks from embryo transfer</time_frame>
    <description>Ultrasound-confirmed intrauterine pregnancy with fetal heartbeat</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biochemical pregnancy</measure>
    <time_frame>Within 8 weeks from embryo transfer</time_frame>
    <description>Positive HCG serum testing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Miscarriage</measure>
    <time_frame>Within 12 weeks from embryo transfer</time_frame>
    <description>Ultrasound-confirmed abortion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Live birth rate</measure>
    <time_frame>Within 41 weeks from embryo transfer</time_frame>
    <description>Delivered fetus after 28 gestational weeks</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Ovarian Endometrioma</condition>
  <condition>Infertility, Female</condition>
  <arm_group>
    <arm_group_label>Surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laparoscopic enucleation of ovarian endometrioma (stripping of the peripheral capsule and coagulation using the lowest energy source available).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prolonged pituitary downregulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment with GnRH-a (triptorelin, goserelin, and leuprolide), with add-back therapy (combined oral contraceptive) for 3-6 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic enucleation of ovarian endometrioma.</intervention_name>
    <description>Laparoscopic enucleation of ovarian endometrioma (stripping of the peripheral capsule and coagulation using the lowest energy source available).</description>
    <arm_group_label>Surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Prolonged pituitary downregulation</intervention_name>
    <description>Treatment with GnRH-a (triptorelin, goserelin, and leuprolide), with add-back therapy (combined oral contraceptive) for 3-6 months.</description>
    <arm_group_label>Prolonged pituitary downregulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Assisted Reproductive Technology (ART)</intervention_name>
    <description>Fresh ART cycle: ovarian stimulation, oocyte retrieval, in vitro fertilization and embryo transfer.</description>
    <arm_group_label>Prolonged pituitary downregulation</arm_group_label>
    <arm_group_label>Surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Indication for ART: compromised tubal function, male factor infertility, other&#xD;
             treatments have failed and/or prolonged infertility of more than 4 years.&#xD;
&#xD;
          -  Age between 18 and 35 years.&#xD;
&#xD;
          -  Ultrasound diagnosis of one ovarian endometriotic cyst with a diameter of 30 mm or&#xD;
             more, according to the International Ovarian Tumor Analysis (IOTA)-criteria for&#xD;
             reliable diagnosis of endometriomas in premenopausal women.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any comorbidity other than ovarian endometrioma.&#xD;
&#xD;
          -  Deep Infiltrating Endometriosis.&#xD;
&#xD;
          -  Previous ovarian surgery.&#xD;
&#xD;
          -  Bilateral endometriomas.&#xD;
&#xD;
          -  The use of donor oocytes/sperm.&#xD;
&#xD;
          -  ART with preimplantation genetic testing, as the number of embryos suitable. for&#xD;
             transfer or cryopreservation is significantly lower compared to normal ART.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio Simone Laganà, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Università degli Studi dell'Insubria</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Antonio Simone Laganà, M.D.</last_name>
    <phone>+393296279579</phone>
    <email>antoniosimone.lagana@asst-settelaghi.it</email>
  </overall_contact>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>October 22, 2018</study_first_submitted>
  <study_first_submitted_qc>October 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 24, 2018</study_first_posted>
  <last_update_submitted>April 28, 2021</last_update_submitted>
  <last_update_submitted_qc>April 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università degli Studi dell'Insubria</investigator_affiliation>
    <investigator_full_name>Antonio Simone Laganà</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Endometrioma</keyword>
  <keyword>Infertility</keyword>
  <keyword>Laparoscopy</keyword>
  <keyword>GnRH-a</keyword>
  <keyword>Assisted Reproduction Technology</keyword>
  <keyword>Reproductive outcomes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

